Dr GARY ADAMS gary.adams@nottingham.ac.uk
ASSOCIATE PROFESSOR
Glargine and degludec: solution behaviour of higher dose synthetic insulins
Adams, Gary G.; Alzahrani, Qushmua; Jiwani, Shahwar I.; Meal, Andrew; Morgan, Paul S.; Coffey, Frank; Kok, Samil; Rowe, Arthur J.; Harding, Stephen E.; Chayen, Naomi; Gillis, Richard B.
Authors
Qushmua Alzahrani
Shahwar I. Jiwani
ANDY MEAL andy.meal@nottingham.ac.uk
Assistant Professor
Paul S. Morgan
Mr FRANK COFFEY frank.coffey@nottingham.ac.uk
CLINICAL CONSULTANT TO THE POSTGRADUATE CLINICAL SKILLS PROG
Samil Kok
Arthur J. Rowe
Professor STEPHEN HARDING STEVE.HARDING@NOTTINGHAM.AC.UK
PROFESSOR OF APPLIED BIOCHEMISTRY
Naomi Chayen
Richard B. Gillis
Abstract
Single, double and triple doses of the synthetic insulins glargine and degludec currently used in patient therapy are characterised using macromolecular hydrodynamic techniques (dynamic light scattering and analytical ultracentrifugation) in an attempt to provide the basis for improved personalised insulin profiling in patients with diabetes. Using dynamic light scattering and sedimentation velocity in the analytical ultracentrifuge glargine was shown to be primarily dimeric under solvent conditions used in current formulations whereas degludec behaved as a dihexamer with evidence of further association of the hexamers (“multi-hexamerisation”). Further analysis by sedimentation equilibrium showed that degludec exhibited reversible interaction between mono- and-di-hexamer forms. Unlike glargine, degludec showed strong thermodynamic non-ideality, but this was suppressed by the addition of salt. With such large injectable doses of synthetic insulins remaining in the physiological system for extended periods of time, in some case 24–40 hours, double and triple dose insulins may impact adversely on personalised insulin profiling in patients with diabetes.
Citation
Adams, G. G., Alzahrani, Q., Jiwani, S. I., Meal, A., Morgan, P. S., Coffey, F., Kok, S., Rowe, A. J., Harding, S. E., Chayen, N., & Gillis, R. B. (2017). Glargine and degludec: solution behaviour of higher dose synthetic insulins. Scientific Reports, 7(1), Article 7287. https://doi.org/10.1038/s41598-017-06642-w
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 15, 2017 |
Online Publication Date | Aug 4, 2017 |
Publication Date | 2017-12 |
Deposit Date | Aug 11, 2017 |
Publicly Available Date | Aug 11, 2017 |
Journal | Scientific Reports |
Electronic ISSN | 2045-2322 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 7 |
Issue | 1 |
Article Number | 7287 |
DOI | https://doi.org/10.1038/s41598-017-06642-w |
Keywords | Diabetes complications; Protein delivery |
Public URL | https://nottingham-repository.worktribe.com/output/876096 |
Publisher URL | https://www.nature.com/articles/s41598-017-06642-w |
Contract Date | Aug 11, 2017 |
Files
s41598-017-06642-w.pdf
(2.8 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
T1 based oxygen-enhanced MRI in tumours; a scoping review of current research
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search